CLR-1502

N/A

Report date: 2025/06/11 10:58:42
NME

Base Information

Drug NameCLR-1502
Drug Alias NameCLR-1500 seriesCLR-1404CLR-1502GLOW-2CLR-1501
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionPI3-kinase class I inhibitorsAnticancer protein kinase inhibitorsProto-oncogene proteins c-akt inhibitors
TargetsPI3-kinase class IProto-oncogene proteins c-akt
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellectar Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A